TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$28.03
-0.48 (-1.68%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+32.8% upside
Low Target
$31.47
Average Target
$37.23
High Target
$57.92
Current Price
$28.03
Current
$28.03
$28.03
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Scenario Analysis
Bear Case
$31.47
12.3%
Low target
Base Case
$37.23
+32.8%
Avg target
Bull Case
$57.92
+106.6%
High target
Risk/Reward
8.7x
Highly favorable
Price in Context
52-Week High
$39.53
-29.1% from high
52-Week Low
$14.39
+94.8% from low
Target vs 52W High
$37.23
-5.8% vs high
Next Earnings Report
Aug 19, 2026
10d
until earnings
EPS Est: $-1.38
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |